EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -10.6% on 4/8/25. The shares closed at $4.13. Moreover, trading volume in this decline was above average at 123% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -23.8% during the last week.
Current PriceTarget Research Rating
EyePoint Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. EyePoint Pharmaceuticals has a neutral Appreciation Score of 58 but a very low Power Rating of 3, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment